126 related articles for article (PubMed ID: 8547060)
1. Novel treatment options in the severe beta-globin disorders.
Rodgers GP; Rachmilewitz EA
Br J Haematol; 1995 Oct; 91(2):263-8. PubMed ID: 8547060
[No Abstract] [Full Text] [Related]
2. Lenti in red: progress in gene therapy for human hemoglobinopathies.
von Kalle C; Baum C; Williams DA
J Clin Invest; 2004 Oct; 114(7):889-91. PubMed ID: 15467825
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic approaches to hemoglobin switching in treatment of hemoglobinopathies.
Stamatoyannopoulos JA; Nienhuis AW
Annu Rev Med; 1992; 43():497-521. PubMed ID: 1374600
[TBL] [Abstract][Full Text] [Related]
4. Recent advance on genome editing for therapy of β-hemoglobinopathies.
Liu JW; Hong T; Qin X; Liang YM; Zhang P
Yi Chuan; 2018 Feb; 40(2):95-103. PubMed ID: 29428902
[TBL] [Abstract][Full Text] [Related]
5. Stem cell gene therapy for the beta-chain hemoglobinopathies. Problems and progress.
Emery DW; Stamatoyannopoulos G
Ann N Y Acad Sci; 1999 Apr; 872():94-107; discussion 107-8. PubMed ID: 10372114
[TBL] [Abstract][Full Text] [Related]
6. A New Era for Hemoglobinopathies: More Than One Curative Option.
Psatha N; Papayanni PG; Yannaki E
Curr Gene Ther; 2017; 17(5):364-378. PubMed ID: 29357790
[TBL] [Abstract][Full Text] [Related]
7. Impact of epigenetic mechanisms on therapeutic approaches of hemoglobinopathies.
Costa D; Capuano M; Sommese L; Napoli C
Blood Cells Mol Dis; 2015 Aug; 55(2):95-100. PubMed ID: 26142322
[TBL] [Abstract][Full Text] [Related]
8. Gene therapy for hemoglobinopathies: are we there yet?
Puthenveetil G; Malik P
Curr Hematol Rep; 2004 Jul; 3(4):298-305. PubMed ID: 15217560
[TBL] [Abstract][Full Text] [Related]
9. [Regulation of the β-globin gene family expression, useful in the search for new therapeutic targets for hemoglobinopathies].
Scheps KG; Varela V
Medicina (B Aires); 2016; 76(6):383-389. PubMed ID: 27959850
[TBL] [Abstract][Full Text] [Related]
10. Prospects of gene therapy for hemoglobinopathies.
Steinberg MH
Am J Med Sci; 1991 Nov; 302(5):298-303. PubMed ID: 1750450
[TBL] [Abstract][Full Text] [Related]
11. Therapeutic manipulation of globin gene expression in the hemoglobinopathies.
Johnson CS
J Natl Med Assoc; 1986 Jul; 78(7):599-600. PubMed ID: 3746928
[No Abstract] [Full Text] [Related]
12. Single and combination drug therapy for fetal hemoglobin augmentation in hemoglobin E-beta 0-thalassemia: Considerations for treatment.
Singer ST; Kuypers FA; Olivieri NF; Weatherall DJ; Mignacca R; Coates TD; Davies S; Sweeters N; Vichinsky EP
Ann N Y Acad Sci; 2005; 1054():250-6. PubMed ID: 16339672
[TBL] [Abstract][Full Text] [Related]
13. Therapeutic challenges in childhood sickle cell disease. Part 1: current and future treatment options.
Amrolia PJ; Almeida A; Halsey C; Roberts IA; Davies SC
Br J Haematol; 2003 Mar; 120(5):725-36. PubMed ID: 12614202
[No Abstract] [Full Text] [Related]
14. Wake-up Sleepy Gene: Reactivating Fetal Globin for β-Hemoglobinopathies.
Wienert B; Martyn GE; Funnell APW; Quinlan KGR; Crossley M
Trends Genet; 2018 Dec; 34(12):927-940. PubMed ID: 30287096
[TBL] [Abstract][Full Text] [Related]
15. Globin gene transfer for treatment of the beta-thalassemias and sickle cell disease.
Sadelain M; Rivella S; Lisowski L; Samakoglu S; Rivière I
Best Pract Res Clin Haematol; 2004 Sep; 17(3):517-34. PubMed ID: 15498721
[TBL] [Abstract][Full Text] [Related]
16. Genetic treatment of the haemoglobinopathies: recombinations and new combinations.
Sadelain M
Br J Haematol; 1997 Aug; 98(2):247-53. PubMed ID: 9266916
[No Abstract] [Full Text] [Related]
17. Treating hemoglobinopathies using gene-correction approaches: promises and challenges.
Cottle RN; Lee CM; Bao G
Hum Genet; 2016 Sep; 135(9):993-1010. PubMed ID: 27314256
[TBL] [Abstract][Full Text] [Related]
18. The recombinant human parvoviruses for gene therapy of hemoglobinopathies.
Dixit M; Tillery MK; Plonk SG; Ohi S
SAAS Bull Biochem Biotechnol; 1990 Jan; 3():63-8. PubMed ID: 1366418
[TBL] [Abstract][Full Text] [Related]
19. Advances in stem cell transplantation and gene therapy in the β-hemoglobinopathies.
Payen E; Leboulch P
Hematology Am Soc Hematol Educ Program; 2012; 2012():276-83. PubMed ID: 23233592
[TBL] [Abstract][Full Text] [Related]
20. Treatment of beta-thalassemia with hydroxyurea (HU)--effects of HU on globin gene expression.
Huang SZ; Ren ZR; Chen MJ; Xu HP; Zeng YT; Rodgers GP; Zeng FY; Schechter AN
Sci China B; 1994 Nov; 37(11):1350-9. PubMed ID: 7865126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
